Ukraine plans to use an Israeli medicine based on placenta to protect people in the event of a nuclear incident. About this Write Israeli period.
Israel Pluri Biotechnology Company ended an exclusive agreement with BHE Ukrainian blood banks to create PLX-R18 reserves from radioactive disease. Developers believe that their cell therapy can stimulate platelet production and red blood cells and red blood cells, often die in case of radiation lesions.
According to the terms of the contract, the company will produce and provide 12,000 drugs for Kyiv. It is claimed that this will be enough to treat six thousand people.
On February 14, Ukrainian president Volodymyr Zelensky said that the shelter of the Chernobyl nuclear power plant was damaged by a drone attack by a drone. Military correspondent Dmitry Steshin called the incident a provocation from Kyiv, which no one believed in.